'Food for special medical purposes' can benefit patients with earliest stages of Alzheimer's disease

Study supports the hypothesis that a food for special medical purposes containing Fortasyn Connect can benefit patients with mild cognitive impairment who are at high risk of progression to the dementia stage of Alzheimer’s disease, according to research published in the Journal of Alzheimer’s Disease Reports.

Source link

Related posts

Protective effects of REM sleep without atonia against obstructive sleep apnea in patients with idiopathic REM sleep behavior disorder.


Prolonged allocentric navigation deficits indicate hippocampal damage in TGA


Researchers highlight opportunities for academic institutions to achieve and maintain research integrity


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy